Diabetes News and Research

Latest Diabetes News and Research

Could DPP4 inhibitors help treat COVID-19?

Researchers and clinicians are scrambling to find ways to combat COVID-19, including new therapeutics and eventually a vaccine.

13 Apr 2020

Novel coronavirus attacks and destroys T cells, just like HIV

The immune system has many components that work together in protecting the body from foreign invaders. One of the most important types of immune cells is T lymphocytes or T cells, a type of white blood cell that acts as the core of adaptive immunity, the system that modifies the immune response to specific pathogens.

13 Apr 2020

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

Type 2 diabetes affects treatment options for patients who have both coronary artery disease and T2D, according to a new American Heart Association Scientific Statement, published today in the Association's flagship journal Circulation.

13 Apr 2020

People with type 2 diabetes and heart disease may benefit from newer therapies

Type 2 diabetes (T2D) may affect treatment options for patients who have both coronary artery disease (CAD) and T2D.

13 Apr 2020

Unraveling interactions between metal ions and peptides may lead to new therapies for diseases

Copper ions could play a key role when peptide folding goes wrong and leads to harmful aggregates.

12 Apr 2020

New clinical trial launches to test efficacy of cell therapy for severe COVID-19 cases

After a lightening round of proposals and reviews, an international team of scientists led by Dr. Camillo Ricordi was granted immediate FDA authorization for a 24-patient clinical trial to test the safety and exploratory efficacy of umbilical cord-derived mesenchymal stem cells to block the life-threatening lung inflammation that accompanies severe cases of COVID-19.

11 Apr 2020

Study demonstrates the benefits of genomic risk assessment in preventing common diseases

A new Finnish study demonstrated the benefits of large-scale genomic information in estimating the risk of onset for cardiac diseases, diabetes and common cancers.

10 Apr 2020

Arizona COVID-19 Genomics Union to study how the virus may be evolving

The Translational Genomics Research Institute, an affiliate of City of Hope, The Pathogen and Microbiome Institute at Northern Arizona University, and the Department of Ecology and Evolutionary Biology at the University of Arizona have formed a union dedicated to tracking the COVID-19 coronavirus, it was announced today.

10 Apr 2020

Hypertensive patients on ACE inhibitors and angiotensin receptor blockers may have improved COVID-19 prognosis

Emerging concerns that common antihypertensive treatment approaches with angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) – jointly known as renin-angiotensin-aldosterone system (RAAS) inhibitors – may exert a negative effect in COVID-19 patients are not grounded in scientific evidence, as reported by researchers in a recent review article published in Mayo Clinic Proceedings journal.

9 Apr 2020

Using computer software to optimize treatment for diabetic kidney diseases

Diabetic kidney diseases are the main cause of kidney failure in industrialized countries. An international, EU-funded R&D project - which is being headed by the Medical University of Innsbruck, and involves collaboration with the Medical University of Vienna and international partners - is being implemented with the aim of using computer software to provide personalized predictions of the disease's progression and bring about improvements in individuals' responses to treatment.

9 Apr 2020

CIHR Institute of Indigenous Peoples’ Health awards NEIHR grant to McGill University

The Canadian Institutes of Health Research's Institute of Indigenous Peoples' Health has awarded a CAD$3.5 million operating grant to Dr. Treena Wasontí:io Delormier of McGill University's School of Human Nutrition.

7 Apr 2020

Research findings could aid in the recognition and management of COVID-19 pneumonia

Researchers have identified the most common clinical characteristics of 109 patients with COVID-19 related pneumonia who died in Wuhan, China in the early stages of the coronavirus pandemic, according to a new study published online in the Annals of the American Thoracic Society.

7 Apr 2020

Dispatch from a country doctor: Seeing patients differently in the time of coronavirus

Patients would often stop by River Bend Family Medicine just to gab with staff at the front desk or bring baked goods to Dr. Matt Hahn.

7 Apr 2020

Researchers identify new biomarker to track the development of NAFLD

Fatty liver disease not associated with alcohol consumption, which is called Nonalcoholic Fatty Liver Disease or NAFLD, affects more than one billion people worldwide.

7 Apr 2020

Brown fat cells can translate energy into heat in an unexpected way

When we are exposed to sufficient cold or exercise, small clusters of brown fat cells in our bodies begin to burn up energy.

6 Apr 2020

Autoimmunity-associated heart dilation linked with heart-failure risk in type 1 diabetes

People with type 1 diabetes, particularly those with poor glycemic control, are at markedly increased risk for cardiovascular disease than the general population.

6 Apr 2020

Healthy lifestyle, greater disease-free life expectancy

For years, doctors have been advocating a healthy diet, more regular exercise, stress relief, and weight control. However, no study has examined a combination of all these factors with the number of years that one can live free of major chronic disease. This could help communicate the benefits of a healthy lifestyle more convincingly than the commonly reported relative risk of disease with each of these risk factors.

6 Apr 2020

Grip strength metrics may be useful screening tool for diabetes risk

A new study in the American Journal of Preventive Medicine, published by Elsevier, reports valuable new grip strength metrics that provide healthcare practitioners with an easy-to-perform, time-efficient screening tool for type 2 diabetes.

6 Apr 2020

Long-standing racial and income disparities seen creeping into COVID-19 care

The new coronavirus doesn’t discriminate. But physicians in public health and on the front lines said they already can see the emergence of familiar patterns of racial and economic bias in the response to the pandemic.

6 Apr 2020

COVID-19 and renin-angiotensin system inhibitors

A new viewpoint article published in the journal JAMA Network in April 2020 deals with the use of a widely used category of cardiovascular medications in COVID-19 patients with hypertension, diabetes, and cardiovascular disease (CVD). These are the most common medical conditions that are found in COVID-19 patients and contribute disproportionately to mortality.

5 Apr 2020

Diabetes News and Research

Latest Diabetes News and Research

Could DPP4 inhibitors help treat COVID-19?

Novel coronavirus attacks and destroys T cells, just like HIV

Newer therapies may benefit patients with type 2 diabetes and coronary artery disease

People with type 2 diabetes and heart disease may benefit from newer therapies

Unraveling interactions between metal ions and peptides may lead to new therapies for diseases

New clinical trial launches to test efficacy of cell therapy for severe COVID-19 cases

Study demonstrates the benefits of genomic risk assessment in preventing common diseases

Arizona COVID-19 Genomics Union to study how the virus may be evolving

Hypertensive patients on ACE inhibitors and angiotensin receptor blockers may have improved COVID-19 prognosis

Using computer software to optimize treatment for diabetic kidney diseases

CIHR Institute of Indigenous Peoples’ Health awards NEIHR grant to McGill University

Research findings could aid in the recognition and management of COVID-19 pneumonia

Dispatch from a country doctor: Seeing patients differently in the time of coronavirus

Researchers identify new biomarker to track the development of NAFLD

Brown fat cells can translate energy into heat in an unexpected way

Autoimmunity-associated heart dilation linked with heart-failure risk in type 1 diabetes

Healthy lifestyle, greater disease-free life expectancy

Grip strength metrics may be useful screening tool for diabetes risk

Long-standing racial and income disparities seen creeping into COVID-19 care

COVID-19 and renin-angiotensin system inhibitors

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Diabetes News and Research

Latest Diabetes News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in